• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

NPS Pharmaceuticals Inc

+ Add to Watchlist

NPSP:US

25.8800 USD 0.7000 2.63%

As of 20:10:00 ET on 04/23/2014.

Snapshot for NPS Pharmaceuticals Inc (NPSP)

Open: 26.5100 Day's Range: 25.5600 - 26.6100 Volume: 1,638,721
Previous Close: 26.5800 52wk Range: 12.4300 - 39.6800 1-Yr Rtn: +95.76%

Stock Chart for NPSP

No chart data available.
  • NPSP:US 25.8800
  • 1D
  • 1M
  • 1Y
26.5800
Interactive NPSP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NPSP

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 136.9312
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.1600
Est. EPS (USD) (12/2014) 0.1890
Est. PEG Ratio 1.5308
Market Cap (M USD) 2,672.48
Shares Outstanding (M) 103.26
30 Day Average Volume 2,071,247
Price/Book (mrq) 25.3184
Price/Sale (ttm) 16.4240
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NPSP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for NPSP

NPS Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of treatment options for patients with rare gastrointestinal and endocrine disorders and serious unmet medical needs.

Francois NaderPresident/CEOEric PauwelsPresident:NPS Pharma Intl
Paul FirutaPresident:US Commercial OpsLuke Matthew BesharExec VP/CFO
More Company Profile & Key Executives for NPSP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil